Resources and Tools

In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.

A recent study published in Drug and Alcohol Dependence found evidence for racial/ethnic disparities in buprenorphine distribution across the United States.

In May, the New England AIDS Education Training Center (NEAETC) published a set of pages dedicated to providing information about and resources for HIV and HIV-related topics.

Clinicians can now access up-to-date evidence-based office-based addiction treatment recommendations for treating opioid use disorder (OUD) on a smartphone app.

This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).